The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 15, 2023

Filed:

Jul. 06, 2021
Applicant:

Csl Limited, Parkville, AU;

Inventors:

Samuel Wright, Westfield, NJ (US);

Martin Imboden, Muensingen, CH;

Reinhard Bolli, Guemligen, CH;

Marcel Waelchli, Thun, CH;

Assignee:

CSL Limited, Victoria, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 31/56 (2006.01); A61K 31/685 (2006.01); A61K 45/06 (2006.01); A61K 31/575 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 9/0019 (2013.01); A61K 9/1275 (2013.01); A61K 31/56 (2013.01); A61K 31/575 (2013.01); A61K 31/685 (2013.01); A61K 45/06 (2013.01);
Abstract

A reconstituted high density lipoprotein formulation having relatively low toxicity comprises an apolipoprotein such as ApoAI or fragment thereof, a lipid and a detergent at a level which is about 5-50% of that which would normally cause liver toxicity upon administration to a human. The lipid is optimally phosphatidylcholine at about 30-50 g/L and the molar ratio of apolipoprotein:lipid is optimally in the range 1:40 to 1:75. The formulation is useful for treating diseases or conditions such as cardiovascular disease, hypercholesterolaemia and hypocholesterolaemia inclusive of acute coronary syndrome (ACS), atherosclerosis and myocardial infarction.


Find Patent Forward Citations

Loading…